Last Price$94.11.8%
Market Cap$46.6B
3.6%
Peers median - 2.5%
6.1%
Peers median - 11.3%
23.8%
Peers median - 29.8%
9.1%
Peers median - 9.0%
Competing with ALC
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$46.6B | 6.4 | $81.3 13.6% overvalued | 9.9% | $9,926.1M | $608.0M | 3.6% | 6.1% | 55.6% | 9.1% | 23.8% | |
$207.3B | 6.9 | $106.1 81.3% overvalued | 41.5% | $8,352.1M | $1,077.2M | 17.2% | 12.9% | 67.5% | 26.8% | 0.0% | |
$66.3B | 6.1 | $262.7 15.0% undervalued | (1.4%) | $20.6B | $2,936.0M | 5.9% | 14.2% | 59.4% | 5.4% | 55.9% | |
$34.6B | 7.6 | $190.6 18.2% overvalued | 29.9% | $4,926.8M | $1,388.4M | 12.9% | 28.2% | 57.9% | 32.9% | 16.0% | |
$18.6B | 5.8 | $92.7 1.2% undervalued | (10.8%) | $3,895.4M | $288.1M | 8.4% | 7.4% | 62.8% | 5.9% | 32.0% | |
$17.9B | 4.7 | $52.7 51.1% undervalued | (16.2%) | $12.9B | $566.0M | (14.0%) | 4.4% | 37.1% | (1.5%) | 191.5% | |
$16.9B | 6.1 | $152.8 33.0% overvalued | (36.3%) | $2,893.1M | $276.4M | (1.9%) | 9.6% | 34.6% | 18.6% | 11.3% | |
$14.7B | 7.3 | $131.7 108.2% undervalued | (15.2%) | $4,038.9M | $1,135.5M | 1.8% | 28.1% | 56.2% | 13.2% | 1.0% | |
$10.4B | 5.2 | $139.9 26.6% overvalued | 50.3% | $2,094.4M | $145.3M | 2.3% | 6.9% | 48.0% | (14.8%) | 69.2% | |
$9,757.8M | 6.5 | $174.5 19.0% undervalued | 4.2% | $3,582.9M | $349.2M | 2.7% | 9.7% | 48.7% | 12.0% | 27.7% | |
$8,979.7M | 5.9 | $29.8 80.8% overvalued | (20.6%) | $616.0M | $131.3M | (8.0%) | 21.3% | 46.9% | (1.2%) | 33.3% |
Compare ALC Valuation Multiples with Peers
LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
General
Valuation Multiple
Financial metrics
Company name
EV/Revenue
Revenue growth
EBITDA margin
Net Income margin
Alcon Inc.ALC
5.0x
8.5%
182.9%
10.3%
Median Peer Set
5.3x
1.7%
15.9%
10.3%
AptarGroup, Inc.ATR
2.9x
2.7%
30.2%
10.5%
Baxter International Inc.BAX
2.3x
(69.5%)
(100.0%)
(6.9%)
Becton, Dickinson and CompanyBDX
4.1x
4.2%
18.3%
8.4%
The Cooper Companies, Inc.COO
5.4x
8.4%
32.2%
10.1%
Hologic, Inc.HOLX
3.2x
(0.0%)
81.1%
19.6%
Intuitive Surgical, Inc.ISRG
24.3x
17.2%
27.7%
27.8%
Masimo CorporationMASI
5.2x
0.6%
(42.5%)
4.0%
Repligen CorporationRGEN
14.4x
(21.1%)
(80.9%)
5.6%
ResMed Inc.RMD
7.1x
10.9%
13.4%
21.8%
West Pharmaceutical Services, Inc.WST
5.8x
(1.9%)
(15.5%)
17.0%
Compare ALC Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does Alcon Inc. (ALC) revenue growth compare to peers and the industry?
Alcon Inc. (ALC) revenue growth is 3.6%, compared to the peers' median of 2.5%.
2. How does Alcon Inc. (ALC) Free Cash Flow (FCF) margin compare to peers and the industry?
Alcon Inc. (ALC) FCF margin is 6.1%, compared to the peers' median of 11.3%.
3. How does Alcon Inc. (ALC) Total Debt to Equity ratio compare to peers and the industry?
Alcon Inc. (ALC) Total Debt to Equity ratio is 23.8%, compared to the peers' median of 29.8%.
4. How does Alcon Inc. (ALC) ROIC (Return on Invested Capital) compare to peers and the industry?
Alcon Inc. (ALC) ROIC is 9.1%, compared to the peers' median of 9.0%.